Access is not the problem, and it never was. Continuity is.
Yes. Nationality is not a barrier to private medical care in Costa Rica, and neither is immigration status. What you need is a physician registered with the Colegio de Médicos y Cirujanos, a laboratory, and a pharmacy — all three of which will see you as a paying patient whether you hold a cédula, a DIMEX or a passport.
The interesting questions are not about permission. They are about which of the two systems you use, and what happens to your care when you leave the country for three months.
Legal residents are required to affiliate with the CCSS, the social security system, as a condition of residency, and contribute monthly. That gives you access to public consultations, medicines on the official list and laboratory work with nothing to pay at the point of use.
Nothing stops you also paying privately, and a great many residents do exactly that — the CCSS for hospital care, chronic prescriptions and emergencies, private care where waiting is the binding constraint. The two are not alternatives you must choose between, and using one does not forfeit the other.
Visitors and non‑residents simply pay privately. There is no registration step and no residency test.
Three things surprise people who have just arrived:
Private laboratories are plentiful in the Central Valley and will draw blood without a hospital admission or a referral queue. Remote consultation is explicitly regulated and lawful, so follow‑up does not require a drive to San José. Most of the medicines used in metabolic management hold Costa Rican sanitary registration and are stocked by ordinary pharmacies.
And prices are published, or at least floored: laboratory tariffs have a legal minimum set by the Colegio de Microbiólogos, which makes a quote something you can check rather than something you have to accept.
The real difficulty for expats is not access. It is continuity.
Metabolic treatment is a year of measurements, not an appointment. If you spend four months a year in Ontario or Minnesota, the questions that actually matter are: who reads the panel drawn while you are away, which laboratory draws it, and who adjusts the dose. Assays differ between laboratories, so a ten per cent change can be a change of laboratory rather than a change in you — worth settling before you book, not after.
Some patients solve this by having bloodwork drawn at home and reviewed remotely here; some use a service in their home country for the draw and keep the clinical relationship in one place. Either works. Neither works by accident.
Whether any of this applies to you — whether a metabolic problem needs treating, and with what — depends on your own measurements and history. This page is about how the system works, not about what you should do inside it.
Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.
Measure my biomarkers